MAPT and Alzheimer disease: Sadly, no disease-modifying treatments are available for AD, and the few approved drugs provide only limited symptomatic relief18; in addition, pharmacological drugs targeting either Aβ or Tau have thus far proven ineffective in halting or reversing cognitive decline19,20.